2022 UK HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts-Blood Banks, Commercial Labs, Hospitals

April 2022 | - | ID: 2C2AB339120DEN
Venture Planning Group

Abstracts

Summary

This report presents detailed analyses of the AIDS diagnostics market in the UK. The report provides test volume and sales forecasts forHIV/HIV-1/2/Combo, HIVAg/HIVNAT,Western Blot, HTLV-I/IIand other confirmatory tests performed in the following market segments:

• Hospitals
• Commercial/Private Laboratories
• Blood Banks
• Physician Offices
• Public Health Laboratories

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

• Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
• Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
• Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
• Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
• Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including VPGMarketResearch's proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies

III. COUNTRY ANALYSIS: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

V. POTENTIAL MARKET ENTRY BARRIERS AND RISK

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. COMPETITIVE ASSESSMENTS

Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujifilm Wako
Fujirebio
Grifols
Hologic
Illumina
Leica Biosystems
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Quest Diagnostics
Quidel
Roche
Scienion
Sequenom/LabCorp
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher